Neglected Diseases

Dengue Fever

Technologies Available from NIH, Universities and Other Non-profit Organizations

NATIONAL INSTITUTES OF HEALTH (NIH)
E-089-2002	Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4
E-120-2001	Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses
E-228-2000	Subgenomic Replicons of the Flavivirus Dengue
E-067-1998	Attenuated Host-Range Restricted Dengue Viruses Derived by Site-Directed Mutagenesis of the Conserved 3-Stem and Loop Structure in Genomic RNA for Use as Vaccines
E-067-1998	Attenuated Host-Range Restricted Dengue Viruses Derived by Site-Directed Mutagenesis of the Conserved 3-Stem and Loop Structure in Genomic RNA for Use as Vaccines
E-493-1985	3-Deazaneplanocin and Method of Preparation

	Overview
	African Trypanosomiasis (Sleeping Sickness)
	Dengue Fever
	General (Vaccines and Biotherapeutics)
	Hepatitis B
	HIV/AIDS
	Intestinal Parasites
	Leprosy
	Lymphatic Filariasis (Elephantiasis)
	Malaria
	Rotavirus
	Schistosomiasis
	Tuberculosis
	Visceral Leishmaniasis